Avita Medical Inc.

RCEL Healthcare Medical Devices

Avita Medical Inc.’s revenue for fiscal 2025 (year ended December 2025) was $71.6 million, up 11.5% from fiscal 2024. In the quarter to June 2026, revenue grew 17.8%, EPS grew 33.8%, free cash flow grew 66.5% and total debt rose 10.5%, each against the same quarter a year earlier. Revenue growth for three consecutive years; insiders bought in the last twelve months.

13.04 0.37 −2.76%
Market cap
$333.1M
P/E
0.0×
Fwd P/E
−3.6×
Dividend yield
—
F-score
3/9
Altman Z
−11.96
Beneish M
−4.09
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
Piotroski F-Score

+8 more TTM periods

4 3 3 3
ROE
(1,746.27%) 799.72% 326.92% 211.55%
ROA
(67.07%) (71.40%) (74.88%) (81.36%)
ROIC
(211.01%) (334.18%) (288.05%) (306.20%)
Return on Tangible Assets
458.93% 261.83% 169.09% 131.98%
Average Days of Receivables
45.44 46.31 49.87 47.62
Free Cash Flow per Share
(26.15) (23.57) (21.22) (16.42)
Free Cash Flow
(37.13) (32.83) (32.40) (25.25)
Other line items

Show all line items

Columns are period end dates